Effect of elastase-like and chymotrypsin-like neutral proteases from human granulocytes on isolated clotting factors.
D001779:Blood Coagulation Factors / Q000378:metabolism*; D002918:Chymotrypsin / Q000097:blood* / Q000494:pharmacology; D005165:Factor V / Q000037:antagonists & inhibitors; D005167:Factor VII / Q000037:antagonists & inhibitors; D005169:Factor VIII / Q000037:antagonists & inhibitors; D005174:Factor XII / Q000037:antagonists & inhibitors; D005176:Factor XIII / Q000037:antagonists & inhibitors; D005340:Fibrinogen / Q000037:antagonists & inhibitors; D005452:Fluoresceins / Q000378:metabolism; D005453:Fluorescence; D006098:Granulocytes / Q000201:enzymology*; D006801:Humans; D007962:Leukocytes / Q000201:enzymology*; D010196:Pancreatic Elastase / Q000097:blood* / Q000494:pharmacology; D011516:Prothrombin / Q000378:metabolism; D000515:alpha 1-Antitrypsin / Q000494:pharmacology
D001779:Blood Coagulation Factors; D005452:Fluoresceins; D000515:alpha 1-Antitrypsin; D005165:Factor V; D005167:Factor VII; D011516:Prothrombin; D005169:Factor VIII; D005174:Factor XII; D005340:Fibrinogen; D005176:Factor XIII; D002918:Chymotrypsin; D010196:Pancreatic Elastase